Cegedim: Organic revenue growth continued to pick up in the first quarter of 2017

Press Release

Quarterly financial information at March 31, 2017
IFRS - Regulated information - Not audited

Cegedim: organic revenue growth continued to pick up in the first quarter of 2017

• The business model transformation continues, in line with Group expectations
• Like-for-like revenues rose 6.9% in Q1 2017
• FY 2017 targets maintained

Boulogne-Billancourt, France, April 27, 2017 after the market close

Cegedim, an innovative technology and services company, posted consolidated Q1 2017 revenues of ?,?113.7 million, up 7.1% on a reported basis and 6.9% like-for-like compared with the same period in 2016.

The business model transformation initiated in fall 2015 is beginning to pay off, as shown by the increase in like-for-like revenue growth to 6.9% in the first quarter of 2017 after a 5.4% rise in the fourth quarter of 2016.

Like-for-like revenue growth at the Health insurance, HR and e-services division continued at almost the same pace as the 13.0% posted in Q4 2016, at 12.5% in Q1 2017. All of the division's activities contributed to the growth.

The Healthcare professionals division posted a like-for-like decline of 0.9% in Q1 2017. The transformation plan should have a beneficial impact on division revenues starting in Q4 2017.

The execution of the transformation plan, the development of a complete BPO offering, the switch over to SaaS format and recent R&D efforts will enhance customer loyalty, create closer client relationships, simplify operating processes, and strengthen our offerings and geographic positions. As the business model transformation is well under way, we expect to see the full impact of this transformation in 2018.

Part of this growth was related to the BPO business, and these activities will continue to negatively affect Group profitability in 2017.

Revenue trends by division

• First quarter 2017

In the first quarter of 2017, Cegedim posted consolidated Group revenues of ?,?113.7 million, up 7.1% on a reported basis. Excluding an unfavorable currency translation effect of 1.3% and a 1.5% boost from acquisitions, revenues rose 6.9%.

The unfavorable currency translation effect of ?,?1.4 million, or 1.5%, was chiefly due to the ?,?1.5 million negative impact of the pound sterling, which represents 11.1% of revenues.

The ?,?1.6 million positive impact from acquisitions, or 1.5%, was due to the acquisition of Futuramedia in France in November 2016.

In like-for-like terms, the Health Insurance, HR and e-services division's revenues rose by 12.5%, whereas the Healthcare professionals division's revenues fell by 0.9%.

Analysis of business trends by division

• Health insurance, HR and e-services

The division's Q1 2017 revenues came to ?,?68.6 million, up 14.9% on a reported basis. The November 2016 Futuramedia acquisition in France made a positive contribution of 2.6%. Currency effects made a negative contribution of 0.2%. Like-for-like revenues rose 12.5% over the period.
The Health insurance, HR and e-services division represented 60.3% of consolidated Group revenues, compared with 56.2% over the same period a year earlier.

All of the businesses in this division contributed to growth in the first quarter. More specifically:

• Cegedim Insurance Solutions, with its iGestion BPO offering for health insurance companies and mutual insurers, posted double-digit growth on the back of a ramp-up in contracts signed in 2015 and 2016. It continued to post robust growth in the third party payment flow management activity, and generated slight growth in software and services devoted to the personal protection insurance sector despite the impact of transitioning to SaaS format.
• The start of operations with new clients of the digital data exchange platform, Global Information Services, which includes payment platforms, enabled Cegedim e-business to post double-digit growth.
• The start of operations with numerous clients on the Cegedim SRH SaaS platform for human resources management resulted in double-digit revenue growth over the quarter.
  • Healthcare professionals

The division's Q1 2017 revenues came to ?,?44.0 million, down 3.6% on a reported basis. Currency effects made a negative contribution of 2.7%. The impact of the March 1, 2017, acquisition of B.B.M. Systems in the UK was negligible. Like-for-like revenues fell 0.9% over the period.
The Healthcare professionals division represented 38.7% of consolidated Group revenues, compared with 43.0% over the same period a year earlier

The decline in first-quarter 2017 revenues was chiefly attributable to:

? Clients in certain markets, are increasingly turning to cloud-based and SaaS offerings;

? In the UK another decline in doctor computerization revenues. On the other hand, the market eagerly welcomed the launch of the first products sold in SaaS format.

?

? In France, the market welcomed the new Smart Rx offering for French pharmacists. The order book grew but is unlikely to impact revenues before the end of the year.

• In the US, Pulse's business experienced a clear decline owing to a challenging comparison with the previous year, which will continue through end-June owing to the reorganization that began in July 2016.

This decline was partly offset by:

• Double-digit growth in products and services designed for physical therapists and nurses in France.
• Double-digit growth in the financial lease business, Cegelease.
  • Activities not allocated

The division's Q1 2017 revenues came to ?,?1.1 million, up 32.8% on a reported basis and like for like. There were no currency effects and no acquisitions or divestments.
The Activities not allocated division represented 0.9% of consolidated Group revenues, compared with 0.7% over the same period a year earlier.

This trend reflects a favorable comparison.

Highlights

To the best of the company's knowledge, apart from the items cited below, there were no events or changes after the accounts were closed that would materially alter the Group's financial situation.

• Tessi litigation

On February 10, 2017, Cegedim was ordered to pay ?,?4,636,000 to the Tessi company for failing to meet certain obligations with respect to an asset sale made on July 2, 2007.

Cegedim has decided to appeal this decision.

• Euris litigation

Cegedim, jointly with IMS Health, is being sued by Euris for unfair competition. Cegedim has filed a motion claiming that IMS Health should be the sole defendant.

• Partial interest rate hedging

To hedge part of its exposure to euro interest rate fluctuations arising from its RCF, the Group carried out an interest rate swap on February 17, 2017. Under the zero-premium swap agreement, Cegedim receives the 1-month Euribor rate if it exceeds 0%, receives nothing otherwise, and pays a fixed rate of 0.2680%.

• Acquisition of B.B.M. Systems in the UK

On February 23, 2017, Cegedim acquired UK company B.B.M. Systems through its Alliadis Europe Ltd subsidiary. The deal strengthens the Group's expertise in developing cloud-based products for general practitioners.

B.B.M. Systems had 2016 revenues of around ?,?0.7 million and earned a profit. It contributes to the Group's scope of consolidation from March 1, 2017.

• Changes to Cegedim SA's Board of Directors

In keeping with the wishes of BPIFrance, Ms. Anne-Sophie H?(C)relle has been appointed to replace Ms. Val?(C)rie Raoul-Desprez on the Board of Directors. The permanent representative of BPIFrance, is now Ms. Marie Artaud-Dewitte, Deputy Head of Legal Affairs at Bpifrance Investissements. She replaces Ms. Anne-Sophie H?(C)relle.

Significant post-closing transactions and events

To the best of the company's knowledge, there were no events or changes after the accounts were closed that would materially alter the Group's financial situation.

Outlook

Cegedim continues to reinvent itself in 2017, pursuing innovation and investing in the future by transforming its business model. The business model transformation is well under way, so growth momentum is expected to pick up in Q4 2017 and lead to improving profitability in the future.

Cegedim reiterates its expectations for 2017:

• Like-for-like revenue growth between 4.0% and 6.0%.
• EBITDA in a range of ?,?66.0 million to ?,?72.0 million inclusive.

Cegedim expects to see the full positive impact of its investments, reorganization and transformation in 2018.

The Group does not expect any significant acquisitions in 2017 and does not disclose earnings projections or estimates.

• Potential impact of Brexit

In 2016, the UK accounted for 12.7% of consolidated Group revenues and 14.8% of consolidated Group EBIT.

Cegedim deals in local currency in the UK, as it does in every country where it is present. Thus Brexit is unlikely to have a material impact on Group EBIT.

With regard to healthcare policy, the Group has not identified any major European programs at work in the UK and expects UK policy to be only marginally affected by Brexit.

• Quarterly statements

Starting in 2017, Cegedim will publish only half-year and full-year results. It will, however, continue to publish revenues quarterly. The next results will be for the period ending June 30, 2017, and will be announced September 21, 2017, after the market closes.

The figures cited above include guidance on Cegedim's future financial performances. This forward-looking information is based on the opinions and assumptions of the Group's senior management at the time this press release is issued and naturally entails risks and uncertainty. For more information on the risks facing Cegedim, please refer to points 2.4, "Risk factors and insurance", and 3.7, "Outlook", of the 2016 Registration Document filed with the AMF on March 29, 2017, under number D.17-0255.

Financial calendar

Additional information

Annexe

Breakdown of revenue by quarter and division

• Year 2017

• Year 2016

Breakdown of revenue by geographic zone and division

• As of March 31, 2017

Breakdown of revenue by currency and division

• As of March 31, 2017

Glossary

Attachments:

http://www.globenewswire.com/NewsRoom/AttachmentNg/53fe2dd3-c45d-40dc-be55-b02597828f3d